Skip to main content
. 2022 Oct 18;51:39. doi: 10.1186/s40463-022-00591-9

Table 1.

The clinical findings, pathologic features and treatment outcomes of the occult neoplasm of facial nerve

Patient Sex/age Final diagnosis Time to referral (mo) Initial HB grade Suspected occult neoplasm Diagnostic Procedure Recurrence Follow-up (mo) Final outcome
Diagnostic delay (mo)* HB grade at referral Reason for suspicion Definitive treatment
1 F/69 Skin SCC 13 2 Yes Facial nerve biopsy (parotidectomy approach) No 46 NED
24 6 Progressive, irreversible Chemoradiation treatment
2 M/33 Parotid ACC 8 5 No Facial nerve biopsy (Incidental finding at facial reanimation surgery) Regional recurrence, POD 40 mo- > Palliative treatment 68 AWD until last follow-up
15 5 Irreversible Radical parotidectomy with neck dissection, temporal bone resection Postoperative radiation
3 M/58 Skin SCC 20 4 Yes Transoral biopsy of inferior alveolar nerve (multiple cranial nerve invasion) Stable disease 22 AWD
21 5 Progressive, irreversible RT
4 M/50 Parotid ACC 15 2 Yes Facial nerve biopsy Lung metastasis, POD 32 mo-> salvage surgery 72 NED
19 6 Progressive, irreversible Radical parotidectomy with neck dissection, temporal bone resection postoperative radiation
5 M/54 Skin SCC 12 2 Yes Infraorbital nerve biopsy Stable disease 30 AWD
21 6 Progressive, irreversible CCRT
6 M/81 Skin SCC 28 5 Yes Transmastoid biopsy Progressive disease 36 AWD until last follow-up
34 6 irreversible Clinical trial†
7 M/79 Facial nerve schwannoma 17 2 Yes No biopsy‡ Stable disease 28 AWD
28 6 Progressive, irreversible Regular follow-up
8 F/56 Facial nerve schwannoma 180 3 Yes No biopsy‡ Stable Disease 24 AWD
180 6 Progressive, irreversible Regular follow-up
9 F/59 Parotid malignant tumor 23 3 Yes Contralateral neck node biopsy 4 AWD until last follow-up
34 6 Progressive, irreversible Recommend surgery and postoperative radiation therapy

HB House-Brackmann; SCC squamous cell carcinoma; ACC adenoid cystic carcinoma; NED no evidence of disease; AWD alive with disease

*Diagnosis delay was defined as the time between initial symptoms of facial weakness and identification of malignancy

Extensive tumor with widespread perineural and dural invasion at the time of pathologic diagnosis

No surgery for tumor resection of infratemporal facial nerve schwannoma